Prediction of sperm extraction in non-obstructive azoospermia patients: a machine-learning perspective
A Zeadna1, N Khateeb2, L Rokach3
1IVF Unit, Division of Obstetrics and Gynecology, Faculty of Health Sciences, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Human Reproduction (Oxford, England)
|June 16, 2020
Summary
A machine-learning model accurately predicts sperm presence in testicular biopsies for non-obstructive azoospermia (NOA) patients. This supports fertility treatment decisions for men with NOA undergoing testicular sperm extraction (TESE).
Area of Science:
- Reproductive Medicine and Urology
- Artificial Intelligence in Healthcare
- Male Infertility Research
Background:
- Non-obstructive azoospermia (NOA) affects male fertility, with testicular sperm extraction (TESE) offering a chance for conception via Intracytoplasmic Sperm Injection (ICSI).
- Predicting TESE success in NOA patients is challenging, lacking validated predictive models.
- Machine learning (ML) has not been previously applied to predict sperm retrieval in NOA.
Purpose of the Study:
- To develop and evaluate a machine-learning-based model for predicting the presence or absence of sperm in testicular biopsies of NOA patients.
- To compare the predictive performance of ML models against traditional statistical methods.
Main Methods:
- Retrospective cohort study of 119 NOA patients undergoing TESE between 1995 and 2017.
- Development of gradient-boosted trees (GBTs) and comparison with multivariate logistic regression models (MvLRM).
- Model performance evaluated using receiver operating characteristic (ROC) curve analysis and leave-one-out cross-validation.
Main Results:
- The GBT model achieved an Area Under the Curve (AUC) of 0.807 (±0.032), outperforming MvLRM (AUC 0.75 ±0.052).
- GBT demonstrated a sensitivity of 91% and specificity of 51%, compared to 97% sensitivity and 25% specificity for MvLRM.
- Successful TESE (presence of sperm) was achieved in 65.3% of the patients; clinical and biological variables like FSH, LH, testosterone, and testicular size were included in the models.
Conclusions:
- Machine-learning models, specifically GBTs, show promise in accurately predicting sperm presence in NOA patients undergoing TESE.
- These ML models can form the basis for a clinical decision support system to aid clinicians and patients in TESE planning.
- Further validation through larger, prospective studies is recommended to confirm these findings.


